To compare a new fetal heart rate monitoring machine with routinely used machine during delivery of baby.
Not Applicable
- Conditions
- Health Condition 1: O68- Labor and delivery complicated byabnormality of fetal acid-base balance
- Registration Number
- CTRI/2024/04/065158
- Lead Sponsor
- Rahul Bhakat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Women with singleton pregnancy.
2. Gestation more than or equal to 32 weeks.
3. Admission in labour ward with labour pains.
Exclusion Criteria
1. Presence of antenatally detected major fetal anomaly.
2. Intrauterine death.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Agreement between the two devices in detecting Fetal heart rate. <br/ ><br>2. Correlation coefficient between the two devices in detecting Fetal heart rate. <br/ ><br> <br/ ><br>Timepoint: Measurement of fetal heart rate for continuous 6 minutes during first and / or second stage of labour only once at enrollment. <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 5. APGAR at 1 and 5 minutes <br/ ><br>6. Degree of resuscitation requiredTimepoint: Neonates after delivery till resuscitation is required;Decision taken regarding delivery of fetusTimepoint: Measurement of fetal heart rate continuously for 6 minutes during first/ second stage of labour during delivery once at the time of enrollment.;Detection of abnormal fetal heart rate/ Fetal distressTimepoint: Fetal heart rate will be continuously measured for 6 minutes during first/ second stage of labour during delivery once.;Number of device adjustments requiredTimepoint: During continuos measurement of fetal heart rate for 6 minutes during first/ second stage of labour.;Patient/ provider device satisfactionTimepoint: During continuous measurement of fetal heart rate for 6 minutes during first/ second stage of labour once.